Expression vector, bacterial, of human TP53, S240N mutant, Gateway(R) expression plasmid
| Clone info. | Expression vector, bacterial, of human TP53, S240N mutant. Gateway(R) expression plasmid. |
|---|---|
| Vector backbone | pETHFFc (Plasmid) |
| Selectable markers | Amp^r |
| Gene/insert name | Human TP53 cDNA |
| Depositor|Developer | DNA Bank, | Murata, Takehide | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
| Ordering forms | Order form [Credit Card Payment MTA, for use for not-for-profit academic purpose [Word Please visit Information of Request for Distribution.[link] |
|---|---|
| Terms and conditions for distribution | 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. |
| Remarks | An additional fee for license fee of Gateway(R) Expression Vector is required. Gateway® Expression clone. Please refer Life Technologies Corporation signs license agreement with RIKEN BRC. |
[open/close]| 必要書類 | 提供依頼書 提供同意書 (MTA, 非営利学術目的用)[Word 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
|---|---|
| MTAに書く使用条件 | 1. 本件リソースは非営利機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。 |
| 備考 | Gateway(R)発現ベクター。ライセンス料相当額を負担して頂きます。 Gateway®テクノロジーを用いた発現クローンです。「Gateway®テクノロジーを用いたクローンの提供と寄託のご案内」をご覧ください。 |
| Catalog # | Resource name | Availability | Shipping form | Fee (non-profit org.) |
|---|---|---|---|---|
| RDB07049 | pETHFF-hsTP53 S240N | Under QC test. Please contact us. | DNA solution |
Materials & Methods section:
| The pETHFF-hsTP53 S240N was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB07049). |
Reference section:
Further references such as user reports and related articles (go to bottom)
Please wait for results of QC test to be uploaded. This clone will be sequenced a portion for examination.
Original, user report and related articles
Featured content